<DOC>
	<DOCNO>NCT01990560</DOCNO>
	<brief_summary>The purpose study determine whether mifepristone effective treatment hyperglycemia due mild hypercortisolism . - To test hypothesis GR blockade mifepristone decrease severity metabolic syndrome feature measure waist circumference , lipid profile , body mass index , blood pressure insulin resistance , measure HOMA-IR score . - To test hypothesis GR blockade mifepristone improve QoL , depression anxiety score , measure validated assessment , patient mild hypercortisolism .</brief_summary>
	<brief_title>Glucocorticoid Receptor Blockade With Mifepristone Patients With Mild Adrenal Hypercortisolism</brief_title>
	<detailed_description />
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Adrenocortical Hyperfunction</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>&gt; 18 year age Incidentally note adrenal nodule &lt; 4 cm benign image characteristic Evidence mild hypercortisolism Evidence diabetes abnormal glucose tolerance contraindication mifepristone Indication unilateral adrenalectomy Evidence adrenal hormone hypersecretion lactate mother woman childbearing age unwilling use effective , nonhormonal form contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>mild hypercortisolism</keyword>
	<keyword>Subclinical Cushing 's Syndrome</keyword>
	<keyword>Preclinical Cushing 's Syndrome</keyword>
</DOC>